HCA Healthcare UK has delivered its first Tumour-Infiltrating Lymphocyte (TIL) therapy for a...
Category - Biotechnology
Lilly launches TuneLab to accelerate AI-driven drug discovery...
Eli Lilly and Company has launched Lilly TuneLab, an artificial intelligence and machine learning...
Sanofi’s Brivekimig Shows Positive Phase 2a Results in...
Sanofi has reported encouraging Phase 2a data for brivekimig, a dual-target Nanobody® molecule...
Novartis to Acquire Tourmaline Bio, Expanding Cardiovascular...
Novartis has announced plans to acquire Tourmaline Bio, strengthening its cardiovascular pipeline...
Libtayo Plus Chemotherapy Delivers Five-Year Survival Benefit in...
Regeneron Pharmaceuticals, Inc. has announced five-year follow-up results from its Phase 3 EMPOWER...
Glycomine Begins Global Phase 2b Clinical Trial of GLM101 for...
Glycomine, Inc., a clinical-stage biotechnology company, has announced the initiation of dosing in...
SeqOne to Acquire Congenica to Establish Global Leader in AI...
SeqOne has entered into a definitive agreement to acquire Congenica, the UK genomics company spun...
AbbVie shares Phase 2 EPCORE® NHL-6 data: outpatient first-full...
AbbVie has reported updated results from the Phase 2 EPCORE® NHL-6 study (NCT05451810) assessing...
Roche Receives CE Mark for Contivue Port Delivery Platform in...
Roche has announced that the European Union has granted CE Mark approval for Contivue®, its Port...
NoPalm Ingredients and NIZO Launch First Yeast Oil Demonstration...
NoPalm Ingredients has partnered with NIZO to establish the first yeast oil demonstration factory...